Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
Giada Zurlo(University of North Carolina at Chapel Hill), Qing Zhang(University of North Carolina at Chapel Hill)
Cited by 47
Related Papers
Tumor hypoxia: From basic knowledge to therapeutic implications
|Seminars in Cancer Biology|2023|180
Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase
|Genes & Development|2014|133
Protein phosphatase 2 regulatory subunit B''Alpha silencing inhibits tumor cell proliferation in liver cancer
|Cancer Medicine|2019|25
Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway
|Oncotarget|2017|24
Function of microRNA‑141 in human breast cancer through cytotoxic CD4+ T cells regulated by MAP4K4 expression
|Molecular Medicine Reports|2018|16